-
effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-236-mental-health-pregnancy-evidence-summary.pdf
April 01, 2021 - • The paucity of evidence does not mean that pharmacotherapy is not beneficial, nor
that harms do … ; a systematic review will help
clarify the balance of benefits and harms. … As a result, most studies could not assert a causal
relationship between exposure and resultant harms … Regarding maternal harms, benzodiazepine before conception may
be associated with an increased risk … By contrast, evidence is voluminous but of low quality on the harms of
pharmacotherapy.
-
effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/for-patients-with-insomnia-how-do-commonly-used-medications-compare-for-effectiveness-and-harms-including-addictive-potential
November 01, 2017 - For patients with insomnia, how do commonly used medications compare for effectiveness and harms … For patients with insomnia, how do commonly used medications compare for effectiveness and harms … For patients with insomnia, how do commonly used medications compare for effectiveness and harms, including … quality of life, sleep quality, fatigue
Describe any health-related risks, side effects, or harms … For patients with insomnia, how do commonly used medications compare for effectiveness and harms
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/s23.pdf
October 01, 2007 - of atypical antipsychotics.21 The review summarized 5
RCTs that discussed harms. … Asymmetric Communication of Benefits and
Harms
Benefits may be presented in relative terms but harms … for both benefits and harms. … for harms). … benefits, and
11% reported only harms.
-
effectivehealthcare-admin.ahrq.gov/products/diagnostic-errors-emergency/protocol
February 01, 2021 - , and serious misdiagnosis-related harms? … serious misdiagnosis-related harms? … , and serious misdiagnosis-related harms
Frequency of diagnostic errors, misdiagnosis-related harms … harms, and serious misdiagnosis-related harms overall and for key clinical conditions (KQ2)
Patient … †Misdiagnosis-related harms are defined as harms resulting from the delay or failure to treat a condition
-
effectivehealthcare-admin.ahrq.gov/products/genitourinary-syndrome/research
March 01, 2025 - Key Question 3: What are the harms (and comparative harms) of hormonal, non-hormonal, and energy-based … to evaluate infrequent but serious harms though most studies did not report frequent serious harms. … This was particularly noticeable in harms reporting; definitions and reporting of harms/adverse effects … frequent serious harms. … but serious harms, though most studies did not report frequent serious harms.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND-0651-131114.pdf
June 20, 2013 - The nominator is also interested in the harms and benefits of the treatment
options. … In patients with low back pain, what are the benefits and harms of identifying risk
from Nominator: … What are the comparative benefits and harms of different pharmacological
therapies for radicular low … What are the comparative benefits and harms of different non-pharmacological,
non-invasive therapies … What are the comparative benefits and harms of combinations of therapies (versus
single therapies or
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/patient-safety-practices-rapid-protocol.pdf
September 09, 2022 - Potential Harms Resulting from Patient-Clinician Real-Time Clinical Encounters using Video-based Telehealth … Review
Evidence-based Practice Center Rapid Review Protocol
Project Title: Potential Harms … What is the frequency and severity of harms associated with use of telehealth in real-time
clinical … What patient safety measures or patient safety indicators have been used to examine the harms
associated … What patient safety practices have been used to prevent or mitigate the harms associated with
use of
-
effectivehealthcare-admin.ahrq.gov/products/patient-safety-telehealth/protocol
July 01, 2023 - Home
Evidence Reports
Making Healthcare Safer IV: Potential Harms … SHARE:
Making Healthcare Safer IV: Potential Harms … Review Questions
What is the frequency and severity of harms associated with use … What patient safety measures or patient safety indicators have been used to examine the harms associated … What patient safety practices have been used to prevent or mitigate the harms associated with use of
-
effectivehealthcare-admin.ahrq.gov/products/hypothyroidism-hyperthyroidism-screening-treatment/research
December 01, 2019 - What are the harms of screening for subclinical thyroid dysfunction? … and treatment benefits and harms. … Since 2002, no studies have directly assessed the benefits or harms of screening. … Treatment harms were neither systematically evaluated nor well described. … the harms of treatment.
-
effectivehealthcare-admin.ahrq.gov/products/chronic-urinary-retention/research
December 01, 2019 - Evidence Reports
Chronic Urinary Retention: Comparative Effectiveness and Harms … SHARE:
Chronic Urinary Retention: Comparative Effectiveness and Harms … Evidence on harms was inconsistently reported across all interventions, and no differences were detected … across treatment groups; however, studies were not adequately powered to detect differences in harms … Project Timeline
Chronic Urinary Retention: Comparative Effectiveness and Harms of Treatments
Oct
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-218-osteoporosis-disposition-comments.pdf
April 23, 2019 - as class-
specific harms for DMB. … , and Technical Expert Panel harms
research priorities. … benefit/”harms”
discussion. … treatments with these harms separately. … Most of the information in the draft report on harms,
particularly on rare harms, was from observational
-
effectivehealthcare-admin.ahrq.gov/products/infantile-hemangioma/research
December 01, 2019 - Review methods
We included comparative studies of interventions, case series addressing harms, and … Steroid harms frequently included Cushingoid facies, irritability/mood changes, and growth retardation … Laser treatment harms included hypopigmentation and scarring. … Beta-blockers and steroids also may cause clinically important harms (moderate SOE for association of … oral propranolol with harms).
-
effectivehealthcare-admin.ahrq.gov/products/major-depressive-disorder/research
December 01, 2019 - Structured Abstract
Objective
To compare the benefits and harms of second-generation antidepressants … For risk of harms, we graded the strength of evidence as moderate for some outcomes of three comparisons … Our confidence in the benefits and harms of SGAs compared with the remaining treatment options is low … Comparative Benefits and Harms of Antidepressant, Psychological, Complementary, and Exercise Treatments … Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/prostate-cancer-therapies-summary.pdf
September 01, 2020 - prostatectomy (RP) may reduce
mortality and metastases more than watchful waiting (WW) but causes more harms … Harms were lowest with AM
compared with RP or EBR plus AD or AS versus photodynamic therapy. … Associated harms were unclear. … Harms are greater
with RP.
AM was compared with RP or EBR plus AD in PSA screen–detected CLPC. … However, it may
also result in an increase in harms.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain_executive.pdf
October 01, 2011 - Key Question Strength of Evidence Conclusion
GI and CV harms: Celecoxib High for GI harms vs.
nonselective … GI and CV harms: Partially
selective NSAIDs
GI harms: Moderate for
meloxicam and etodolac
(fewer trials … GI and CV harms:
Nonselective NSAIDs
GI harms: High for naproxen,
ibuprofen, and diclofenac
(consistent … Key Question Strength of Evidence Conclusion
GI and CV harms:
Nonselective NSAIDs
(continued)
CV harms … GI and CV harms: Aspirin Moderate for GI and CV
harms (many trials, but almost
exclusively in patients
-
effectivehealthcare-admin.ahrq.gov/products/osteoporosis-fracture-prevention/research
January 01, 2020 - Long-term oral hormone therapies reduce hip and clinical fractures but increase multiple serious harms … Trials were used for incident fractures and harms, and controlled observational studies were included … for additional harms. … Harms and controls were inconsistently defined. Conclusions. … Evidence is limited regarding ODT holidays for fractures and harms.
-
effectivehealthcare-admin.ahrq.gov/products/headaches-pregnancy/research
June 01, 2022 - A single primary study provided insufficient (direct) evidence to make conclusions about the harms of … ; fetal/child harms were not reported. … Our a priori approach to examining harms of relevant medications in this review was restricted to harms … can cause some of the harms, irrespective of exposure to interventions. … of indication, some well-accepted harms of treatment were not addressed.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/pressure-ulcer-treatment_executive.pdf
May 01, 2013 - They were included for the assessment of
harms if they reported on harms of treatments for which
data … (continued)
Harms: Local Wound Applications
Dressings and topical therapies Moderate Harms reported … harms by ulcer characteristics. … harms by patient characteristics. … harms by patient care setting.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND__0250_05-20-2010.pdf
January 01, 2010 - What are the benefits and harms of rhythm control compared to rate control
(including newer agents)? … What are the benefits and harms of strict versus more
lenient rate control?
2. … What are the benefits and harms of different anticoagulation and antiplatelet agents
and monitoring … What are the benefits and harms of antiarrhythmic agents for acute conversion of
AF to sinus rhythm … What are the benefits and harms of ACEIs, ARBs and statins in the prevention of
new AF and progression
-
effectivehealthcare-admin.ahrq.gov/products/collections/making-healthcare-safer-IV
January 01, 2025 - COLLECTION
February 6, 2024
A Continuous Updating of Patient Safety Harms … Potential Harms Resulting From Patient- Clinician Real-Time Clinical Encounters Using Video-Based Telehealth … Reducing Adverse Drug Events Related to Anticoagulant Use in Adults Deprescribing To Reduce Medication Harms … of Service
Rapid Evidence Product | Sep 14, 2023
Making Healthcare Safer IV: Potential Harms … Anticoagulant Use in Adults
Rapid Evidence Product | Feb 1, 2024
Deprescribing To Reduce Medication Harms